Abstract: The present disclosure relates to compositions including monoglycerides and alkyl esters of fatty acids. An exemplary embodiment includes about 15 wt % to about 99 wt % of one or more monoglycerides of a C4-C28 fatty acid, and about 1 wt % to about 75 wt % of one or more alkyl esters of a C8-C20 fatty acid.

Abstract: The present invention is generally directed to systems and methods for data ingestion related to business insurance. It is more specifically directed to systems and methods for developing a code set for a business insurance product. In one aspect, the present invention provides a method of developing an insurance code set. The method comprises the steps of: using one or more data ingestion tools to identify and extract claim events from available databases; translating each claim event into one or more sentences using a natural language processing model; storing the one or more sentences in a database in a tabular format; accessing the tabular format and assigning a code to each entry, thereby developing an insurance code set.

Abstract: The present application discloses the preparation and use of attenuated tumor-targeted bacteria vectors for the delivery of one or more primary effector molecule(s) to the site of a solid tumor. The primary effector molecule(s) of the invention is used in the methods of the invention to treat a solid tumor cancer such as a carcinoma, melanoma, lymphoma, or sarcoma. The invention relates to the surprising discovery that effector molecules, which may be toxic when administered systemically to a host, can be delivered locally to tumors by attenuated tumor-targeted bacteria with reduced toxicity to the host. The application also discloses to the delivery of one or more optional effector molecule(s) (termed secondary effector molecules) which may be delivered by the attenuated tumor-targeted bacteria in conjunction with the primary effector molecule(s).